IP Verse

Sandoz Ag opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Sandoz Ag

Patent Number:
EP4082531
Title:
Ophthalmic Suspension Composition
Applicant:
BAUSCH & LOMB INCORPORATED
Opposition Date:
Jul 9, 2024
Patent Number:
EP3175853
Title:
Antineoplastic Combinations Of Neratinib And Capecitabine
Applicant:
WYETH LLC
Opposition Date:
Jul 2, 2024
Patent Number:
EP3578169
Title:
Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol
Applicant:
GLAXO GROUP LIMITED
Opposition Date:
Jun 27, 2024
Patent Number:
EP3263106
Title:
Method For Suppressing Bitterness Of Quinoline Derivative
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
Jun 20, 2024
Patent Number:
EP3307271
Title:
Methods Of Using Pyruvate Kinase Activators
Applicant:
AGIOS PHARMACEUTICALS, INC.
Opposition Date:
Jun 13, 2024
Patent Number:
EP3650019
Title:
Fluticasone Furoate In The Treatment Of Copd
Applicant:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Opposition Date:
Jun 6, 2024
Patent Number:
EP3713919
Title:
Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-Sulfonamide
Applicant:
AGIOS PHARMACEUTICALS, INC.
Opposition Date:
May 2, 2024
Patent Number:
EP3110449
Title:
Medical Use Of A Dpp-4 Inhibitor
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Mar 13, 2024
Patent Number:
EP3810201
Title:
Gip/Glp1 Agonist Compositions
Applicant:
ELI LILLY AND COMPANY
Opposition Date:
Feb 23, 2024
Patent Number:
EP3263110
Title:
Solid Preparation
Applicant:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Opposition Date:
Feb 8, 2024

Latest patents of Sandoz Ag opposed by its competitors

Patent:
EP3373914
Grant Date:
Jun 1, 2022
Title:
Storage Stable Composition Comprising Rifaximin Alpha
Oppositions:
1
Patent:
EP3536311
Grant Date:
Dec 22, 2021
Title:
Storage Stable Composition Comprising Rifaximin Alpha
Oppositions:
1
Patent:
EP3434265
Grant Date:
Jul 7, 2021
Title:
Pharmaceutical Composition Containing Rifaximin Alpha & Delta
Oppositions:
3
Patent:
EP3390358
Grant Date:
Sep 23, 2020
Title:
Crystalline Eravacycline Bis-Hydrochloride
Oppositions:
1
Patent:
EP3416627
Grant Date:
Apr 22, 2020
Title:
Oral Dosage Form Comprising Rifaximin In Form Beta
Oppositions:
1
Patent:
EP2785702
Grant Date:
Jan 22, 2020
Title:
Crystalline Dapagliflozin Hydrate
Oppositions:
1
Patent:
EP2975050
Grant Date:
May 29, 2019
Title:
Quantification Of Misfolded Tnfr2:Fc
Oppositions:
1
Patent:
EP2977372
Grant Date:
May 8, 2019
Title:
Polymorphs Of Febuxostat
Oppositions:
1
Patent:
EP2988733
Grant Date:
Mar 27, 2019
Title:
Pharmaceutical Composition Containing Crystalline Macitentan
Oppositions:
1
Patent:
EP3003277
Grant Date:
Feb 20, 2019
Title:
Process For The Preparation Of A Pharmaceutical Composition Comprising Rivaroxaban
Oppositions:
1

Competitors of Sandoz Ag

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

ALFASIGMA S.P.A.

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND

Want to track Sandoz Ag?

Feel free to send us a message here and we will get back to you